In GBM, ligand binding to CXCR4 induces conformational changes that activate PI3K-AKT, JAK/STAT, and MEK1/2-Erk1/2 pathways, leading to the activation of STAT3, an oncogenic transcription factor involved in GBM growth23. The gene discussed is MAP2K1; the disease is glioblastoma.